Clinical Supply Management

Clinical Supply Management - Axcellant

Clinical Supply Management

  1. lut 28, 2025

What Does 'Clinical Supply Management’ Mean?

Clinical Supply Management refers to the process of planning, manufacturing, packaging, labeling, and distributing investigational medicinal products for use in clinical trials. It encompasses the entire lifecycle of clinical supplies, from initial forecasting to final reconciliation and destruction of unused products.

This crucial aspect of clinical research ensures that the right drug or placebo is available at the right time, in the right quantity, and at the right location for each study participant. Effective Clinical Supply Management is essential for maintaining the integrity of clinical trials, adhering to regulatory requirements, and optimizing the use of resources throughout the study.

Why Is the 'Clinical Supply Management’ Important in Clinical Research?

Clinical Supply Management is crucial for ensuring the scientific validity and ethical conduct of clinical trials. It directly impacts patient safety, data integrity, and regulatory compliance by guaranteeing that study participants receive the correct investigational product in the proper dosage and form.

Effective Clinical Supply Management also plays a vital role in the operational and financial aspects of clinical research. It helps minimize waste, reduce costs, and prevent delays in trial timelines by optimizing inventory levels and distribution processes, thereby contributing to the overall efficiency and success of clinical studies.

Good Practices and Procedures

  1. Implement a robust forecasting system that accounts for patient recruitment rates, site activation timelines, and potential protocol amendments to ensure accurate supply projections.
  2. Establish a temperature-controlled supply chain with real-time monitoring to maintain product integrity from manufacturing to patient administration.
  3. Develop a flexible, adaptive packaging strategy that allows for quick response to dosing changes or cohort expansions without compromising blinding or regulatory compliance.
  4. Implement a validated Interactive Response Technology (IRT) system to manage randomization, drug assignment, and site-level inventory tracking in real-time.
  5. Create a comprehensive reconciliation process that includes regular site-level audits and a secure chain of custody for returned or unused investigational products.

Related Terms

Read more

How clinical trials can become a strategic asset for biotech startups

Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…

Advancing PET Innovation at SNMMI 2025

Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…

Insights from Turku PET Symposium 2025

Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…